{"id":425,"title":"[ESBL and carbapenemases in Enterobacteriaceae].","abstract":"Carbapenemase-producing enterobacteria (CPE) spread all over the world during the last years, causing serious infections with increasing frequency. Very few new drugs active against CPE are expected to be clinically available. Studies summarized in this review show that there is yet room to improve our therapeutic approaches, in the treatment of infections due to CPE.","date":"2014-12-31","categories":"Bacterial Infections and Mycoses","split":"test","url":"http://www.ncbi.nlm.nih.gov/pubmed/25549375","annotations":[{"name":"Therapy","weight":0.750676,"wikipedia_article":"http://en.wikipedia.org/wiki/Therapy"},{"name":"Infection","weight":0.632844,"wikipedia_article":"http://en.wikipedia.org/wiki/Infection"},{"name":"Drug","weight":0.614077,"wikipedia_article":"http://en.wikipedia.org/wiki/Drug"},{"name":"Drug development","weight":0.440478,"wikipedia_article":"http://en.wikipedia.org/wiki/Drug_development"},{"name":"Beta-lactamase","weight":0.0297972,"wikipedia_article":"http://en.wikipedia.org/wiki/Beta-lactamase"},{"name":"Enterobacteriaceae","weight":0.0297972,"wikipedia_article":"http://en.wikipedia.org/wiki/Enterobacteriaceae"},{"name":"Frequency","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Frequency"}]}
